These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27498749)

  • 21. Antiangiogenic potentials of ahpatinins obtained from a Streptomyces species.
    Han JM; Jang JP; Jang JH; Ahn JS; Jung HJ
    Oncol Rep; 2020 Feb; 43(2):625-634. PubMed ID: 31894333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.
    Xing Y; Tu J; Zheng L; Guo L; Xi T
    Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.
    Banskota S; Gautam J; Regmi SC; Gurung P; Park MH; Kim SJ; Nam TG; Jeong BS; Kim JA
    PLoS One; 2016; 11(1):e0148133. PubMed ID: 26824764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling.
    Kang Y; Regmi SC; Kim MY; Banskota S; Gautam J; Kim DH; Kim JA
    Arch Pharm Res; 2015 Feb; 38(2):249-60. PubMed ID: 25547980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
    Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
    Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.
    Terzuoli E; Donnini S; Giachetti A; Iñiguez MA; Fresno M; Melillo G; Ziche M
    Clin Cancer Res; 2010 Aug; 16(16):4207-16. PubMed ID: 20682710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity.
    Zhao R; Sun L; Lin S; Bai X; Yu B; Yuan S; Zhang L
    Oncol Rep; 2013 Apr; 29(4):1379-86. PubMed ID: 23404207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo.
    Shukla K; Sonowal H; Saxena A; Ramana KV
    Vascul Pharmacol; 2019 Apr; 115():18-25. PubMed ID: 30634049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
    Kim A; Ma JY
    Phytomedicine; 2019 Apr; 57():95-104. PubMed ID: 30668328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
    Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
    J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
    Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
    J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of indatraline on angiogenesis suppression through HIF-1α-mediated VEGF inhibition.
    Yen CN; Cho YS; Kwon HJ
    Biochem Biophys Res Commun; 2017 Apr; 485(2):349-354. PubMed ID: 28216154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
    Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
    Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.